Info@ThinkPinkRocks.org

Metabolon, Inc., a world leader in metabolomics-based diagnostic tests and research services, announced today that it has raised $15 million in a Series E financing through the issuance of preferred stock.

Original post:
Metabolon raises $15 million in Series E financing

Scroll to Top